scholarly article | Q13442814 |
P356 | DOI | 10.1111/FEBS.12236 |
P698 | PubMed publication ID | 23480797 |
P50 | author | Jaroslaw Szczyrba | Q43852131 |
Helge Taubert | Q56519855 | ||
Friedrich Grässer | Q88368821 | ||
Arndt Hartmann | Q89782316 | ||
Roopika Menon | Q90316695 | ||
P2093 | author name string | Bernd Wullich | |
Robert Stoehr | |||
Sven Wach | |||
Elke Nolte | |||
Martin Hart | |||
Wolf Wieland | |||
P2860 | cites work | MicroRNA145 targets BNIP3 and suppresses prostate cancer progression | Q24304475 |
Real-time quantification of microRNAs by stem-loop RT-PCR | Q24535510 | ||
The functional significance of microRNA-145 in prostate cancer | Q24606503 | ||
Putative tumor suppressor miR‐145 inhibits colon cancer cell growth by targeting oncogene friend leukemia virus integration 1 gene | Q24632934 | ||
p53 represses c-Myc through induction of the tumor suppressor miR-145 | Q24644779 | ||
MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1 | Q24647663 | ||
miRecords: an integrated resource for microRNA-target interactions | Q24655642 | ||
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. | Q27824849 | ||
Oncomirs - microRNAs with a role in cancer | Q27860773 | ||
Analyzing real-time PCR data by the comparative C(T) method | Q28131831 | ||
Interaction of two multifunctional proteins. Heterogeneous nuclear ribonucleoprotein K and Y-box-binding protein | Q28144366 | ||
Identification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMT | Q28744173 | ||
Understanding alternative splicing: towards a cellular code | Q29615085 | ||
A combined computational-experimental approach predicts human microRNA targets | Q29619021 | ||
Binding of the heterogeneous ribonucleoprotein K (hnRNP K) to the Epstein-Barr virus nuclear antigen 2 (EBNA2) enhances viral LMP2A expression | Q31081505 | ||
Antibody-based detection of ERG rearrangement-positive prostate cancer | Q34009867 | ||
Isolation of a human prostate carcinoma cell line (DU 145) | Q34255312 | ||
Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer | Q34803786 | ||
TMPRSS2-ERG-mediated feed-forward regulation of wild-type ERG in human prostate cancers. | Q35165354 | ||
ETS transcription factors and their emerging roles in human cancer | Q36280928 | ||
ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor | Q36710981 | ||
miRNAs get an early start on translational silencing | Q36965104 | ||
Pleiotropic biological activities of alternatively spliced TMPRSS2/ERG fusion gene transcripts | Q37003441 | ||
Alternative splicing and biological heterogeneity in prostate cancer | Q37573399 | ||
Widespread deregulation of microRNA expression in human prostate cancer. | Q38297946 | ||
Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma. | Q39540283 | ||
Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a | Q40001339 | ||
MicroRNA expression profiling in prostate cancer | Q40110318 | ||
TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer | Q40236533 | ||
Suitable reference genes for relative quantification of miRNA expression in prostate cancer | Q41475887 | ||
Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomas | Q41854285 | ||
Gene networks and microRNAs implicated in aggressive prostate cancer | Q42128568 | ||
The microRNA profile of prostate carcinoma obtained by deep sequencing | Q43852104 | ||
The LARK/RBM4a protein is highly expressed in cerebellum as compared to cerebrum | Q45285560 | ||
Identification of ZNF217, hnRNP-K, VEGF-A and IPO7 as targets for microRNAs that are downregulated in prostate carcinoma | Q46495042 | ||
ERG is a megakaryocytic oncogene. | Q47677556 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | microRNA | Q310899 |
prostate cancer | Q181257 | ||
P304 | page(s) | 2105-2116 | |
P577 | publication date | 2013-04-08 | |
P1433 | published in | FEBS Journal | Q1388041 |
P1476 | title | The proto-oncogene ERG is a target of microRNA miR-145 in prostate cancer | |
P478 | volume | 280 |
Q47246071 | A Peptide Nucleic Acid against MicroRNA miR-145-5p Enhances the Expression of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in Calu-3 Cells |
Q37597723 | Analysis of Argonaute Complex Bound mRNAs in DU145 Prostate Carcinoma Cells Reveals New miRNA Target Genes. |
Q61809489 | Circular RNA: a novel biomarker and therapeutic target for human cancers |
Q92667802 | Co-staining of microRNAs and their target proteins by miRNA in situ hybridization and immunohistofluorescence on prostate cancer tissue microarrays |
Q38843392 | Deciphering the function of non-coding RNAs in prostate cancer. |
Q96765767 | Decreased miR-200b-3p in cancer cells leads to angiogenesis in HCC by enhancing endothelial ERG expression |
Q41967527 | Demethylation of the MIR145 promoter suppresses migration and invasion in breast cancer |
Q37295759 | Emerging roles of circRNA_001569 targeting miR-145 in the proliferation and invasion of colorectal cancer |
Q92072526 | Ensemble of decision tree reveals potential miRNA-disease associations |
Q35608000 | Expression of ERG protein in prostate cancer: variability and biological correlates |
Q47224473 | GIMDA: Graphlet interaction-based MiRNA-disease association prediction. |
Q40769779 | Identification of miR-34a-target interactions by a combined network based and experimental approach |
Q26783563 | Implications of miR cluster 143/145 as universal anti-oncomiRs and their dysregulation during tumorigenesis |
Q64121783 | Inferring microRNA-disease association by hybrid recommendation algorithm and unbalanced bi-random walk on heterogeneous network |
Q100945947 | Loss of RBMS1 as a regulatory target of miR-106b influences cell growth, gap closing and colony forming in prostate carcinoma |
Q35961920 | Loss of miR-449a in ERG-associated prostate cancer promotes the invasive phenotype by inducing SIRT1. |
Q33591474 | MCMDA: Matrix completion for MiRNA-disease association prediction |
Q35225191 | MiR-145 inhibits metastasis by targeting fascin actin-bundling protein 1 in nasopharyngeal carcinoma |
Q39051553 | MiRNA regulation of TRAIL expression exerts selective cytotoxicity to prostate carcinoma cells |
Q34571491 | MicroRNA-145: a potent tumour suppressor that regulates multiple cellular pathways |
Q38667234 | Non-coding RNAs in Prostate Cancer: From Discovery to Clinical Applications |
Q26782530 | Prognostic role of microRNA-145 in prostate cancer: A systems review and meta-analysis |
Q38958582 | Reciprocal regulation of PCGEM1 and miR-145 promote proliferation of LNCaP prostate cancer cells |
Q26747155 | Regulation of endothelial homeostasis, vascular development and angiogenesis by the transcription factor ERG |
Q39067486 | TMPRSS2-ERG gene fusions induce prostate tumorigenesis by modulating microRNA miR-200c |
Q89998761 | The deregulation of miR-17/CCND1 axis during neuroendocrine transdifferentiation of LNCaP prostate cancer cells |
Q38444138 | The oncogene ERG: a key factor in prostate cancer |
Q38859577 | The roles of microRNAs in the progression of castration-resistant prostate cancer |
Q26995383 | Tumor suppressor microRNAs: a novel non-coding alliance against cancer |
Q36583369 | WBSMDA: Within and Between Score for MiRNA-Disease Association prediction |
Q45942966 | [Minutes of the meeting of the Working Group on Uropathology]. |
Q38921152 | miR-145 inhibits invasion and metastasis by directly targeting Smad3 in nasopharyngeal cancer. |
Q39120421 | miR-145 suppresses osteogenic differentiation by targeting Sp7. |
Q91933172 | miR-34a as hub of T cell regulation networks |
Q38791639 | microRNA 338-3p exhibits tumor suppressor role and its down-regulation is associated with adverse clinical outcome in prostate cancer patients |
Q53767542 | microRNAs and Prostate Cancer. |
Q34978603 | μHEM for identification of differentially expressed miRNAs using hypercuboid equivalence partition matrix. |
Search more.